Get started
Author

Ana Belén Rubio

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
2023 · Miquel Serra-Burriel, Adrià Juanola, et al. · The Lancet · 172
Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population‐based study
2021 · Elisa Pose, Guillem Pera, et al. · Liver International · 41
Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis
2024 · Ann Thu Ma, Cristina Solé, et al. · Journal of Hepatology · 32
PDF
Liver fibrosis screening increases alcohol abstinence
2024 · Emma Avitabile, Jordi Gratacós-Ginès, et al. · JHEP Reports · 30
PDF
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
2022 · Isabel Graupera, Maja Thiele, et al. · BMC Public Health · 30
PDF
Patient-derived liver organoids recapitulate liver epithelial heterogeneity and enable precision modeling of alcohol-related liver disease
2025 · Silvia Ariño, Raquel Ferrer-Lorente, et al. · Journal of Hepatology · 16
Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome
2021 · Cristina Solé, Ann T. Ma, et al. · Liver International · 14
Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling
2023 · Jordi Gratacós-Ginès, Emma Avitabile, et al. · Clinical Gastroenterology and Hepatology · 3
Patients with alcohol-related cirrhosis who recompensate on follow-up have a characteristic metabolomic profile with differential concentrations of lipid and amino-acid metabolites
2023 · Helena Hernàndez-Èvole, Jordi Gratacos, et al. · Journal of Hepatology · 1
Alcoholic foamy degeneration: a unique variant of ALD that shows a characteristic pattern of gene expression with upregulation of lipid metabolism and mitochondrial genes and downregulation of fibrosis genes
2022 · Jordi Gratacós-Gines, Delia Blaya, et al. · Journal of Hepatology · 1
Hepatocyte–Neutrophil Interaction in the Liver via SAA-FPR2 Is Key in the Pathogenesis of Alcohol-Associated Hepatitis
2025 · Alicia Martínez-Álvarez, Aina Rill, et al. · EMJ Hepatology
PDF
FRI-429 Generation of patient-derived liver organoids from needle biopsies for precision disease modeling of metabolic-associated steatotic liver disease
2025 · Raquel Ferrer-Lorente, David Gómez-Cabeza, et al. · Journal of Hepatology
SAT-501 Steatosis predicts poor abstinence rates in patients with alcohol use disorder
2025 · Queralt Herms, Jordi Gratacós-Gineès, et al. · Journal of Hepatology
OS-031-YI Hepatocyte-neutrophil interaction in the liver via SAA-FPR2 is key in the pathogenesis of alcohol-associated hepatitis
2025 · Alicia Martínez-Álvarez, Aina Rill, et al. · Journal of Hepatology
Patient-derived liver biopsy organoids enable precision alcohol-associated liver disease modeling
2025 · Silvia Ariño, Laura Zanatto, et al. · bioRxiv (Cold Spring Harbor Laboratory)
WED-055 Effect of long-term treatment with Simvastatin and Rifaximin in mitochondrial and proinflammatory pathways in patients with decompensated cirrhosis. A single-cell RNA seq analysis in PBMCs
2024 · Adrià Juanola, Núria Planell, et al. · Journal of Hepatology
OS-005-YI Single-cell RNA sequencing analysis in alcohol-related liver disease identifies specific cell subpopulations characterized by an inflammatory profile in alcohol-associated hepatitis
2024 · Jordi Gratacós-Ginès, Alex Guillamon-Thiery, et al. · Journal of Hepatology
WED-284-YI The Fatty Liver Index (FLI) is more accurate than FIB-4 for detection of advanced liver fibrosis in patients with type-2 Diabetes Mellitus (T2DM) in Primary Care
2024 · Ruth Nadal, Adrià Juanola, et al. · Journal of Hepatology
THU-056 Soluble PD-L1 levels as predictors of ACLF in decompensated cirrhosis: findings from two independent cohorts
2024 · Adrià Juanola, Gabriel Mezzano, et al. · Journal of Hepatology
Changes in frailty as a predictor of readmission risk in patients with liver cirrhosis. Preliminary results
2023 · Martina Perez, Marta Cervera, et al. · Journal of Hepatology
Serum PDL1 levels are associated with increased risk of bacterial infections in non-hospitalised patients with cirrhosis
2023 · Adria Juanola, Gabriel Mezzano, et al. · Journal of Hepatology
Beneficial effects of a screening programme for alcohol-related liver fibrosis with transient elastography in people with alcohol use disorder promoting alcohol abstinence
2023 · Emma Avitabile, Helena Hernandéz Evole, et al. · Journal of Hepatology
Patients with risk factors for liver diseases associated with hepatic steatosis constitute the target population for liver fibrosis assessment in primary care
2023 · Rosario Hernández, Jordi Hoyo, et al. · Journal of Hepatology
Refractory ascites in cirrhosis is associated with a major psychological burden in patients with cirrhosis and caregivers
2023 · Ana Belen Rubio Garcia, Rebeca Moreira, et al. · Journal of Hepatology
Blood metabolomics unveils mitochondrial dysfunction as a potential key feature in the pathogenesis of hepatorenal syndrome
2022 · Ann T Ma, Adria Juanola, et al. · Journal of Hepatology
Works count: 32
Citation count: 340
H-index: 7
I10-index: 7
Year
Topic
Type